Wallis MG - Search Results

1

Insulin-mediated hemodynamic changes are impaired in muscle of Zucker obese rats.

Wallis MG, Wheatley CM, Rattigan S, Barrett EJ, Clark AD, Clark MG. Wallis MG, et al. Diabetes. 2002 Dec;51(12):3492-8. doi: 10.2337/diabetes.51.12.3492. Diabetes. 2002. PMID: 12453905

2

Reduced glycogen phosphorylase activity in denervated hindlimb muscles of rat is related to muscle atrophy and fibre type.

Wallis MG, Appleby GJ, Youd JM, Clark MG, Penschow JD. Wallis MG, et al. Life Sci. 1999;64(4):221-8. doi: 10.1016/s0024-3205(98)00557-8. Life Sci. 1999. PMID: 10027756

3

Insulin stimulates laser Doppler signal by rat muscle in vivo, consistent with nutritive flow recruitment.

Clark AD, Barrett EJ, Rattigan S, Wallis MG, Clark MG. Clark AD, et al. Among authors: wallis mg. Clin Sci (Lond). 2001 Mar;100(3):283-90. Clin Sci (Lond). 2001. PMID: 11222114

4

Exercise training improves insulin-mediated capillary recruitment in association with glucose uptake in rat hindlimb.

Rattigan S, Wallis MG, Youd JM, Clark MG. Rattigan S, et al. Among authors: wallis mg. Diabetes. 2001 Dec;50(12):2659-65. doi: 10.2337/diabetes.50.12.2659. Diabetes. 2001. PMID: 11723047

5

Blood flow and muscle metabolism: a focus on insulin action.

Clark MG, Wallis MG, Barrett EJ, Vincent MA, Richards SM, Clerk LH, Rattigan S. Clark MG, et al. Among authors: wallis mg. Am J Physiol Endocrinol Metab. 2003 Feb;284(2):E241-58. doi: 10.1152/ajpendo.00408.2002. Am J Physiol Endocrinol Metab. 2003. PMID: 12531739 Free article. Review.

6

Acute glucosamine-induced insulin resistance in muscle in vivo is associated with impaired capillary recruitment.

Wallis MG, Smith ME, Kolka CM, Zhang L, Richards SM, Rattigan S, Clark MG. Wallis MG, et al. Diabetologia. 2005 Oct;48(10):2131-9. doi: 10.1007/s00125-005-1887-z. Epub 2005 Jul 30. Diabetologia. 2005. PMID: 16059714

7

The microvasculature in insulin resistance and type 2 diabetes.

Clark MG, Barrett EJ, Wallis MG, Vincent MA, Rattigan S. Clark MG, et al. Among authors: wallis mg. Semin Vasc Med. 2002 Feb;2(1):21-31. doi: 10.1055/s-2002-23506. Semin Vasc Med. 2002. PMID: 16222593 Review.

8

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet Diabetes Endocrinol. 2023 Dec;11(12):905-914. doi: 10.1016/S2213-8587(23)00253-X. Epub 2023 Oct 18. Lancet Diabetes Endocrinol. 2023. PMID: 37865101 Free PMC article. Clinical Trial.

9

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet Child Adolesc Health. 2024 Mar;8(3):190-200. doi: 10.1016/S2352-4642(23)00316-4. Epub 2024 Jan 22. Lancet Child Adolesc Health. 2024. PMID: 38272046 Free article. Clinical Trial.

10

Vasopressin is a physiological substrate for the insulin-regulated aminopeptidase IRAP.

Wallis MG, Lankford MF, Keller SR. Wallis MG, et al. Am J Physiol Endocrinol Metab. 2007 Oct;293(4):E1092-102. doi: 10.1152/ajpendo.00440.2007. Epub 2007 Aug 7. Am J Physiol Endocrinol Metab. 2007. PMID: 17684103 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters